Services
Online Inquiry
Enzyme-responsive liposomes are a commonly utilized form of stimuli-responsive liposomes, belonging to the smart drug delivery systems. Creative Biolabs specializes in the development of enzyme-responsive liposomes, tailor-made to revolutionize targeted drug delivery.
Enzymes, biological catalysts produced by living cells, are involved in nearly all biochemical and metabolic processes within biological systems. In areas of tumors or inflammation, changes in the expression of specific enzymes can be observed, such as proteases, phosphatases, and glycosidases. Using these enzymes as triggers for stimuli-responsive liposomes can mediate the targeted accumulation of drugs at the desired biological locations, thereby improving therapeutic efficacy and reducing side effects.
Enzyme-responsive liposomes, also referred to as enzyme-sensitive or enzyme-activated liposomes, undergo degradation, disassembly, or morphological changes when exposed to specific enzymatic environments, leading to drug release. The mechanism of drug release following enzyme exposure involves alterations in the structural integrity of the lipid bilayer; detachment of a protective polymeric layer, enhancing cellular internalization; and cleavage of a lipopeptide or lipopolymer embedded within the bilayer; the activation of a prodrug contained within the liposomes.
Fig.1 The mechanism of drug release from stimuli-responsive liposomes.1, 2
The design principle of enzyme-responsive liposomes involves the conjugation of enzyme-substrate fragments to the liposomal structure through covalent bonds, hydrophobic interactions, or electrostatic interactions, thus integrating them as part of the liposome and endowing them with enzyme sensitivity. Various enzymes, such as Cathepsin B, Hyaluronidase, and Matrix Metalloproteinases, have been utilized in the construction of enzyme-sensitive liposomes. By leveraging their substrates, enzyme-responsive liposomes can be developed to target different pathological environments.
Enzymes | Types of enzymes | Enzyme Substrate | Pathological Characteristics |
Secreted phospholipase A2 (sPLA2) | Extracellular enzymes | The acyl chain at sn-2 position in a phospholipid. | Highly expressed in inflammatory diseases, atherosclerosis, and cancer. |
Matrix metalloproteinases (MMPs) | Extracellular enzymes | Short peptide linkers connect TAT liposomes to PEG chains. | Elevated expression in inflammatory diseases, cardiovascular diseases, and cancer. |
Urokinase plasminogen activator (uPA) | Extracellular enzymes | Arg-Ser bond in peptides. | Highly expressed in cancers such as colon, breast, bladder, and ovarian tumors. |
Cathepsin B | Intracellular enzyme | Extracellular matrix proteins and cell adhesion proteins. | Highly expressed in various cancers, it is involved in the occurrence, invasion, metastasis, and autophagy of cancers. |
Phospholipase A2 (PLA2) | Extracellular and intracellular enzymes | Phospholipids. | Overexpressed in various cancers such as pancreatic, breast, lung, and prostate |
Hyaluronidase (HAase) | Extracellular enzymes | Hyaluronan. | Elevated expression in various cancers, is associated with tumor angiogenesis and cell migration. |
Prostate-specific antigen (PSA) | Extracellular enzymes | Spermatin | Highly expressed in prostate cancer. |
α-amylase | Extracellular and intracellular enzymes | α-1,4-glucoside bond | Overexpression in breast cancer, lung cancer, and other cancers. |
Compared to other types of stimuli-responsive liposomes, enzyme-responsive liposomes offer the following advantages:
As a pioneer in enzyme-responsive liposome development, Creative Biolabs is at the forefront of advanced drug delivery systems. We are your gateway to the cutting-edge world of enzyme-responsive liposomes. Contact us now to unlock the future of targeted therapeutics and propel your scientific advancements forward.
References